Tag: AbbVie
Mylan launches Humira biosimilar Hulio across Europe
Mylan has launched Hulio, a biosimilar to AbbVie's Humira (adalimumab), in major markets in Europe, a month after its approval from the European Commission for ... Read More
Humira biosimilar Cyltezo meets objective in phase 3 plaque psoriasis trial
German pharma company Boehringer Ingelheim said that Cyltezo, a biosimilar to AbbVie psoriasis drug Humira, achieved clinical equivalence to the reference product in a phase ... Read More
Tolero, AbbVie to explore venetoclax alvocidib combo for AML
Tolero Pharmaceuticals said that its cyclin-dependent kinase 9 (CDK9) inhibitor alvocidib will be combined with AbbVie leukemia drug venetoclax to evaluate their potential in their ... Read More
Hyrimoz EC approval : Novartis biosimilar of AbbVie Humira approved in EU
Hyrimoz EC approval : Novartis’ Sandoz has bagged approval for Hyrimoz (adalimumab), a biosimilar of AbbVie’s Humira (adalimumab), in Europe for all indications of the ... Read More